Clinical Trial Update: TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults [NA]

View source ↗

Summary

A clinical trial update indicates that TEOSYAL RHA 1 is currently recruiting in Chinese adults for the correction of moderate to severe tissue volume deficiency…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infraorbital Hollows

Drugs mentioned

• TEOSYAL RHA 1 (Hyaluronic acid dermal filler)

Snippet

Sponsor: Teoxane SA | Conditions: Infraorbital Hollows | NA | Status: RECRUITING